Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5015205 | 0.82 | KIF11 (0.33) | ALDH1A1 | |
| SCHEMBL5015417 | 0.82 | KIF11 (0.35) | — | |
| SCHEMBL7996476 | 0.82 | ALDH1A1 (0.35) | ALDH1A1MAPK1 | |
| SCHEMBL28807262 | 0.82 | ALDH1A1 (0.35) | ALDH1A1MAPK1 | |
| SCHEMBL27979361 | 0.82 | ALDH1A1 (0.35) | ALDH1A1MAPK1 | |
| SCHEMBL2517442 | 0.82 | ALDH1A1 (0.35) | ALDH1A1MAPK1 | |
| SCHEMBL28180007 | 0.82 | ALDH1A1 (0.35) | ALDH1A1MAPK1 | |
| SCHEMBL14562749 | 0.82 | ALDH1A1 (0.35) | ALDH1A1MAPK1 | |
| SCHEMBL28464164 | 0.81 | ALDH1A1 (0.31) | ALDH1A1MAPK1 | |
| SCHEMBL5011851 | 0.81 | ALDH1A1 (0.31) | ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7417142-B2 | Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, INC. (US) | 2008-08-26 | — | — | US | disclosed |
| US-20060030718-A1 | Cobalt-based catalysts for the cyclization of alkenes | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-02-09 | — | — | US | disclosed |
| US-20050124596-A1 | Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2005-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060030718-A1 | Cobalt-based catalysts for the cyclization of alkenes | PPOX, HCCS, ICOSLG | FABP4 4351/4885ALDH1A1 3259/4885MAPK1 4649/4885 |
| US-20050124596-A1 | Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same | PPOX, PPIF, HMBS | FABP4 3317/4885ALDH1A1 953/4885MAPK1 4736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.